Trial Profile
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2018
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 04 Jan 2018 Status changed from recruiting to completed.
- 19 Dec 2014 New trial record